PetMed Express, Inc. (PETS) P/E Ratio History
Historical price-to-earnings valuation from 2002 to 2025
Loading P/E history...
PETS Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, PetMed Express, Inc. (PETS) trades at a price-to-earnings ratio of -7.7x, with a stock price of $2.30 and trailing twelve-month earnings per share of $-2.63.
The current P/E is 107% below its 5-year average of 103.1x. Over the past five years, PETS's P/E has ranged from a low of 10.6x to a high of 850.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, PETS trades at a 134% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, PETS trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PETS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PETS P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $10B | 26.0 | - | +893% | |
| $752M | 86.8 | - | +109% | |
| $3B | 21.2 | - | +184% | |
| $7B | 50.3 | - | -4% | |
| $37B | 14.5Lowest | 1.21Best | +10% | |
| $2B | 36.3 | 4.85 | +1883%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
PETS Historical P/E Data (2002–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | $4.82 | $0.01 | 845.6x | +2085% | |
| FY2023 Q4 | Fri Mar 31 2023 00:00:00 GM | $16.24 | $0.02 | 850.3x | +2097% |
| FY2023 Q3 | Sat Dec 31 2022 00:00:00 GM | $17.70 | $0.57 | 31.1x | -20% |
| FY2023 Q2 | Fri Sep 30 2022 00:00:00 GM | $19.52 | $0.78 | 25.0x | -35% |
| FY2023 Q1 | $19.90 | $0.96 | 20.7x | -46% | |
| FY2022 Q4 | $25.80 | $1.04 | 24.8x | -36% | |
| FY2022 Q3 | Fri Dec 31 2021 00:00:00 GM | $25.26 | $1.08 | 23.4x | -40% |
| FY2022 Q2 | $26.87 | $1.25 | 21.5x | -44% | |
| FY2022 Q1 | Wed Jun 30 2021 00:00:00 GM | $31.85 | $1.36 | 23.4x | -39% |
| FY2021 Q4 | Wed Mar 31 2021 00:00:00 GM | $35.17 | $1.53 | 23.0x | -41% |
| FY2021 Q3 | $32.06 | $1.54 | 20.8x | -46% | |
| FY2021 Q2 | Wed Sep 30 2020 00:00:00 GM | $31.62 | $1.50 | 21.1x | -46% |
Average P/E for displayed period: 38.7x
See PETS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PETS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PETS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPETS — Frequently Asked Questions
Quick answers to the most common questions about buying PETS stock.
Is PETS stock overvalued or undervalued?
PETS trades at -7.7x P/E, below its 5-year average of 103.1x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does PETS's valuation compare to peers?
PetMed Express, Inc. P/E of -7.7x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is PETS's PEG ratio?
PETS PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2002-2025.